The observation of low-energy edge photoluminescence and its beneficial effect on the solar cell efficiency of Ruddlesden−Popper perovskites has unleashed an intensive research effort to reveal its origin. This effort, however, has been met with more challenges as the underlying material structure has still not been identified; new modelings and observations also do not seem to converge. Using twodimensional (2D) (BA) 2 (MA) 2 Pb 3 Br 10 as an example, we show that threedimensional (3D) MAPbBr 3 is formed due to the loss of BA on the edge. This self-formed MAPbBr 3 can explain the reported edge emission under various conditions, while the reported intriguing optoelectronic properties such as fast exciton trapping from the interior 2D perovskite, rapid exciton dissociation, and long carrier lifetime can be understood via the self-formed 2D/3D lateral perovskite heterostructure. The 3D perovskite is identified by submicron infrared spectroscopy, the emergence of X-ray diffraction (XRD) signature from freezer-milled nanometer-sized 2D perovskite, and its photoluminescence response to external hydrostatic pressure. The revelation of this edge emission mystery and the identification of a self-formed 2D/3D heterostructure provide a new approach to engineering 2D perovskites for high-performance optoelectronic devices.

Collagen quantity and integrity play an important role in understanding diseases such as myelofibrosis (MF). Label-free mid-infrared spectroscopic imaging (MIRSI) has the potential to quantify collagen while minimizing the subjective variance observed with conventional histopathology. Infrared (IR) spectroscopy with polarization sensitivity provides chemical information while also estimating tissue dichroism. This can potentially aid MF grading by revealing the structure and orientation of collagen fibers. Simultaneous measurement of collagen structure and biochemical properties can translate clinically into improved diagnosis and enhance our understanding of disease progression. In this paper, we present the first report of polarization-dependent spectroscopic variations in collagen from human bone marrow samples. We build on prior work with animal models and extend it to human clinical biopsies with a practical method for high-resolution chemical and structural imaging of bone marrow on clinical glass slides. This is done using a new polarization-sensitive photothermal mid-infrared spectroscopic imaging scheme that enables sample and source independent polarization control. This technology provides 0.5 µm spatial resolution, enabling the identification of thin (≈1 µm) collagen fibers that were not separable using fingerprint wavenumber Fourier transform infrared (FT-IR) imaging at diffraction-limited resolution ( ≈ 5 µm). Finally, we propose quantitative metrics to identify fiber orientation from discrete band images (amide I and amide II) measured under three polarizations. Previous studies have used a pair of orthogonal polarization measurements, which is insufficient for clinical samples since human bone biopsies contain collagen fibers with multiple orientations. Here, we address this challenge and demonstrate that three polarization measurements are necessary to resolve orientation ambiguity in clinical bone marrow samples. This is also the first study to demonstrate the ability to spectroscopically identify thin collagen fibers (≈1 µm diameter) and their orientations, which is critical for accurate grading of human bone marrow fibrosis.

Mid-infrared Spectroscopic Imaging (MIRSI) provides spatially-resolved molecular specificity by measuring wavelength-dependent mid-infrared absorbance. Infrared microscopes use large numerical aperture objectives to obtain high-resolution images of heterogeneous samples. However, the optical...

Mid-infrared spectroscopic imaging (MIRSI) is an emerging class of label-free techniques being lever- aged for digital histopathology. Modern histopathologic identification of ovarian cancer involves tissue staining followed by morphological pattern...

Mid-infrared spectroscopic imaging (MIRSI) is an emerging class of label-free, biochemically quantitative technologies targeting digital histopathology. Conventional histopathology relies on chemical stains that alter tissue color. This approach is qualitative, often making histopathologic examination subjective and difficult to quantify. MIRSI addresses these challenges through quantitative and repeatable imaging that leverages native molecular contrast. Fourier transform infrared (FTIR) imaging, the best-known MIRSI technology, has two challenges that have hindered its widespread adoption: data collection speed and spatial resolution. Recent technological breakthroughs, such as photothermal MIRSI, provide an order of magnitude improvement in spatial resolution. However, this comes at the cost of acquisition speed, which is impractical for clinical tissue samples. This paper introduces an adaptive compressive sampling technique to reduce hyperspectral data acquisition time by an order of magnitude by leveraging spectral and spatial sparsity. This method identifies the most informative spatial and spectral features, integrates a fast tensor completion algorithm to reconstruct megapixel-scale images, and demonstrates speed advantages over FTIR imaging while providing spatial resolutions comparable to new photothermal approaches.

No abstract

No abstract

No abstract